Clinical Research Directory

Inclusion Criteria: \- CT-confirmed Acute Uncomplicated Diverticulitis: Eligible patients should have a confirmed diagnosis of acute uncomplicated diverticulitis based on in-hospital CT scans. The condition must be defined as an infection limited to the colon, not extending to the peritoneum, and the patients should not require antibiotics treatment for their diverticulitis. This definition ensures that the study focuses on cases of uncomplicated diverticulitis. \- Admission to Odense University Hospital (Odense/Svendborg): Participants must be admitted to Odense University Hospital in Odense or Svendborg for the diagnosis and initial management of acute uncomplicated diverticulitis Exclusion Criteria: * Inability to provide Informed Consent: Patient who are unable to comprehend the study information and provide informed consent due to cognitive impairment, language barriers or any other reason will be excluded. * Cognitive or Physical Impairment: Patients with disabilities that hinder their ability to comply with the study procedures, either cognitively or physically, will be excluded. * Complicated Diverticulitis: patients with complicated diverticulitis, as defined by the presence of abscesses, fistulas, perforations, or other severe complications on the CT scan, will not be eligible for participation. * CT Findings Requiring Biopsy or Polyp Removal: Individuals with CT findings indicating the need for colonoscopy to perform biopsy (e.g., suspected cancer) or for polyp removal will not be eligible for the study. * Presence of Other Gastrointestinal Diseases: Patients with other gastrointestinal diseases, for such as IBD, will be excluded to maintain a homogeneous study population. * Immunocompromised Patients: Individuals with known immunodeficiency disorders or undergoing immunosuppressive thearapy will be excluded due to potential safety concerns associated with FMT. * Impaired Renal Function: Patients with impaired renal function may be more susceptible to potential risks or complications associated with experimental intervention, and their inclusions could confound the results or increase the likelihood of adverse evenets. * History of FMT: Patients with a previous history of FMT will be excluded rom the study to avoid any potential confounding factors. * Pregnant and Lactation: Pregnant or lactating individuals will not be included to ensure the safety of both the mother and the fetus/infant.. * Allergies to Active Substances in the Trial: Patients with known allergies to the active substances administered in the trial will not be eligible for participation. * Participation in Other Clinical Trials: Individuals currently participating in other clinical trials involving investigational drugs or interventions will not be eligible to avoid potential interference with study outcomes